Side-by-Side Comparison · 2026

Lanreotide vs Pasireotide

Lanreotide vs Pasireotide — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

Lanreotide
Hormone Modulator / Somatostatin Analog

Lanreotide is a synthetic octapeptide somatostatin analog that preferentially binds somatostatin receptor subtypes 2 and 5 (SSTR2, SSTR5). Formulated as a proprietary Autogel depot for once-monthly deep subcutaneous injection, it provides sustained suppression of growth hormone, ...

Calculate Lanreotide dose →
Pasireotide
Hormone Modulator / Somatostatin Analog

Pasireotide is a second-generation somatostatin analog with a significantly broader receptor binding profile than octreotide or lanreotide, binding SSTR1, SSTR2, SSTR3, and SSTR5 with high affinity. Crucially, its strong SSTR5 binding enables suppression of ACTH secretion from pi...

Calculate Pasireotide dose →
Key Parameters
Parameter Lanreotide Pasireotide
Category Hormone Modulator / Somatostatin Analog Hormone Modulator / Somatostatin Analog
Research FDA Approved FDA Approved
Half-Life ~28 days (Autogel depot) ~12 hours (SC); ~25-30 days (LAR)
Typical Dose 60-120 mg every 28 days 0.3-0.9 mg BID (SC); 10-40 mg/month (LAR)
Frequency Monthly (every 28 days) Twice daily (SC); monthly (LAR)
Route Deep subcutaneous injection (Autogel) Subcutaneous injection (SC); intramuscular (LAR)
FDA Status Approved (acromegaly, GEP-NETs) Approved (Cushing disease, acromegaly)

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Calculate Lanreotide Calculate Pasireotide
Frequently Asked Questions
What is the difference between Lanreotide and Pasireotide?
Lanreotide: Lanreotide is a synthetic octapeptide somatostatin analog that preferentially binds somatostatin receptor subtypes 2 and 5 (SSTR2, SSTR5). Formulated as a proprietary Autogel depot for once-monthly de... Pasireotide: Pasireotide is a second-generation somatostatin analog with a significantly broader receptor binding profile than octreotide or lanreotide, binding SSTR1, SSTR2, SSTR3, and SSTR5 with high affinity. C...
Which has a longer half-life, Lanreotide or Pasireotide?
Lanreotide half-life: ~28 days (Autogel depot). Pasireotide half-life: ~12 hours (SC); ~25-30 days (LAR).
Can you stack Lanreotide and Pasireotide?
Lanreotide and Pasireotide are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.